BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12366663)

  • 21. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative intensity-modulated arc therapy for cervical and endometrial cancer: a prospective report on toxicity.
    Vandecasteele K; Tummers P; Makar A; van Eijkeren M; Delrue L; Denys H; Lambert B; Beerens AS; Van den Broecke R; Lambein K; Fonteyne V; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):408-14. PubMed ID: 22377596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of raltitrexed/cisplatin with concurrent radiation therapy in treating advanced cervical cancer.
    Li XY; Liu L; Xie XM; Zhou C
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3491-6. PubMed ID: 25491626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
    Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
    Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
    Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
    Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
    Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
    Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.
    Nagar H; Boothe D; Parikh A; Yondorf M; Parashar B; Gupta D; Holcomb K; Caputo T; Chao KS; Nori D; Wernicke AG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):665-9. PubMed ID: 24138915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin.
    Ikushima H; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kishida Y; Iwamoto S; Takegawa Y; Kudoh T; Nishitani H
    Radiat Med; 2006 Feb; 24(2):115-21. PubMed ID: 16715672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery.
    Lee YS; Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Tumori; 2010; 96(4):553-9. PubMed ID: 20968134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer.
    Ren Y; Huang X; Shan B; Wu X; Huang X; Shi D; Wang H
    Gynecol Oncol; 2016 Jan; 140(1):58-63. PubMed ID: 26607778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
    Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience.
    Dogan NU; Yavas G; Yavas C; Ata O; Yılmaz SA; Celik C
    Arch Gynecol Obstet; 2013 Oct; 288(4):845-50. PubMed ID: 23553195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.